What to Watch When Codexis Reports 2019 Operating Results
The stock has tumbled to start 2020. Can the next business update provide any relief to shareholders?
Here's Why Iovance Biotherapeutics Shares Soared as Much as 39.6%
Bloomberg reports that the company has been toying with the idea of a sale.
Here's Why Guardant Health Tumbled Today
The company expects losses to more than double in 2020, which caught Wall Street analysts by surprise.
Here's Why Clovis Oncology Lost as Much as 11.8% Today
Investors are nervous heading into the company's fourth-quarter and full-year 2019 earnings report.
Here's Why Epizyme Is Tumbling Today
The pharma company released full-year 2019 operating results.
Lithium: 3 Things Investors Need to Know
Lithium is bound to be one of the most important materials of the 21st century. Is your portfolio positioned for the opportunity?
Here's Why Aerie Pharmaceuticals Jumped as Much as 14.4% Today
The eye-care company reported better-than-expected fourth-quarter 2019 product revenue.
Here's Why Livent Stock Tumbled Today
The lithium producer disappointed investors with initial full-year 2020 guidance and production delays, but its long-term potential remains intact.
Repligen Signals Gene Therapy Strength With 2019 Earnings Report
Guidance for 2020 appears to have spooked investors, but the bioprocess leader is on a solid long-term trajectory.
Here's Why Agenus Tumbled Today
Results from an experimental combination therapy were impressive, but they might not be impressive enough.
Here's Why Albemarle Rose as Much as 11.6% Today
Investors cheered the company's fourth-quarter and full-year 2019 earnings report.
Here's Why Invitae Stock Is Tumbling Today
The genetic testing company reported full-year 2019 operating results.
Here's Why Twist Bioscience Stock Rose as Much as 14.8% Today
The company announced a public offering of common stock.
Here's Why SunPower Is Soaring Today
An industry peer echoed SunPower's previous comments that, at this time, the coronavirus epidemic in China isn't expected to have a major impact on first-quarter 2020 operations.
Agenus Stock Rises Ahead of Investor Day Presentation
The biopharma is scheduled to update investors and Wall Street analysts on two important pipeline programs on Feb. 20.
Here's Why Enphase Energy Stock Is Soaring Today
The solar hardware company reported full-year 2019 operating results.
Here's Why Inovio Pharmaceuticals Popped Today
The pharmaceutical company received a lot of positive media attention over the weekend.
2 Top Stocks Under $20
These pharma stocks have gone in different directions in the last year, but both hold promise for forward-thinking investors.
About to Buy Penny Stocks? Look at These 2 Companies First
These healthcare stocks offer high risk and high reward, but they aren't nearly as risky as penny stocks.
Here's Why Avrobio Fell as Much as 16.4% Today
The small-cap biopharmaceutical company announced a public stock offering.